First-trimester combined screening is effective for the detection of unbalanced chromosomal translocations at 11 to 12 weeks of gestation, Reprod. Sci, vol.21, pp.594-600, 2014. ,
First trimester screening for other trisomies than trisomy 21, 18, and 13, Prenat. Diagn, vol.35, pp.612-619, 2015. ,
Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: Implications for contingent models of non-invasive prenatal testing, Ultrasound Obstet. Gynecol, vol.51, pp.487-492, 2018. ,
Sequencing of Circulating Cell-free DNA during Pregnancy, N. Engl. J. Med, vol.379, pp.464-473, 2018. ,
The clinical utility of genome-wide non invasive prenatal screening, Prenat. Diagn, vol.37, pp.593-601, 2017. ,
Perinatal outcomes following cell-free DNA screening in >32 000 women: Clinical follow-up data from a single tertiary center, Prenat. Diagn, vol.38, pp.755-764, 2018. ,
Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: A systematic review and meta-analysis, Ultrasound Obstet. Gynecol, vol.45, pp.16-26, 2015. ,
Risk of miscarriage following amniocentesis or chorionic villus sampling: Systematic review of literature and updated meta-analysis, Ultrasound Obstet. Gynecol, vol.54, pp.442-451, 2019. ,
Mid-trimester preterm premature rupture of membranes (PPROM): Etiology, diagnosis, classification, international recommendations of treatment options and outcome, J. Perinat. Med, vol.46, pp.465-488, 2018. ,
Axelsson, O. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping, BJOG, vol.110, pp.392-399, 2003. ,
Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities, Am. J. Obstet. Gynecol, vol.214, pp.1-6, 2016. ,
Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood, Clin. Chem, vol.57, pp.1042-1049, 2011. ,
Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting, Am. J. Obstet. Gynecol, vol.204, pp.1-11, 2011. ,
High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma, PLoS ONE, vol.8, 2013. ,
Microarray-based cell-free DNA analysis improves noninvasive prenatal testing, Fetal Diagn. Ther, vol.36, pp.282-286, 2014. ,
Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci, Prenat. Diagn, vol.32, pp.1233-1241, 2012. ,
Single-Nucleotide Polymorphism-Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort, Obstet. Gynecol, vol.124, pp.210-218, 2014. ,
Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing, Clin. Chem, vol.56, pp.1279-1286, 2010. ,
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci. Transl ,
Prenatal cell-free DNA screening test failures: A systematic review of failure rates, risks of Down syndrome, and impact of repeat testing, Genet. Med, vol.20, pp.1312-1323, 2018. ,
Noninvasive Fetal Trisomy (NIFTY) test: An advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies, BMC Med. Genom, vol.5, 2012. ,
Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing, Proc. Natl. Acad. Sci, vol.111, pp.7415-7420, 2014. ,
Diagnostic accuracy of random massively parallel sequencing for non-invasive prenatal detection of common autosomal aneuploidies: A collaborative study in Europe, Prenat. Diagn, vol.34, pp.185-191, 2014. ,
SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy, Prenat. Diagn, vol.33, pp.643-649, 2013. ,
Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma, Prenat. Diagn, vol.33, pp.591-597, 2013. ,
Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing, Prenat. Diagn, vol.35, pp.999-1004, 2015. ,
Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions, Clin. Genet, vol.93, pp.293-300, 2018. ,
TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands, Am. J. Hum. Genet, vol.105, pp.1091-1101, 2019. ,
Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease, Sci. Transl. Med, vol.9, 2017. ,
Cell-free DNA testing of an extended range of chromosomal anomalies: Clinical experience with 6388 consecutive cases, Genet. Med, vol.19, pp.169-175, 2017. ,
Rapport médical et scientifique de l'assistance médicale à la procréation et de la génétique humaines en France. In Prenatal Diagnosis and Preimplantation Genetic Diagnosis, p.23, 2017. ,
Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management, Eur. J. Hum. Genet, vol.23, pp.1286-1293, 2015. ,
Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: Results of the TRIDENT study, Genet. Med, vol.20, pp.480-485, 2018. ,
Rare autosomal trisomies: Important and not so rare, Prenat. Diagn, vol.38, pp.765-771, 2018. ,
Detection of rare autosomal trisomies through non-invasive prenatal testing: Benefits for pregnancy management, Ultrasound Obstet. Gynecol, vol.53, pp.129-130, 2019. ,
Chromoanagenesis and cancer: Mechanisms and consequences of localized, complex chromosomal rearrangements, Nat. Med, vol.18, pp.1630-1638, 2012. ,
Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis, J. Clin. Med, vol.3, pp.809-837, 2014. ,
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis, Ultrasound Obstet. Gynecol, vol.50, pp.302-314, 2017. ,
Cell-free DNA analysis in maternal blood: Comparing genome-wide versus targeted approach as a first-line screening test, J. Matern. Fetal Neonatal Med, 2019. ,
Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA, Genet. Med, vol.22, pp.309-316, 2020. ,
Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation, Acta Obstet. Gynecol. Scand, vol.99, pp.722-730, 2020. ,
Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers, Eur. J. Med. Genet, vol.63, 2020. ,
Genome-wide cfDNA screening: Clinical laboratory experience with the first 10,000 cases, Genet. Med, vol.19, pp.1332-1337, 2017. ,
Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes, Genet. Med, 2019. ,
Non-invasive prenatal testing to detect chromosome aneuploidies in 57,204 pregnancies, Mol. Cytogenet, vol.12, 2019. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI